Finland· FI-REL-REL46459

Letifend

A leishmania product containing rec.protein q from leishmania infantum mon-1, registered in Finland by LETI Pharma, S.L.U.. The same ATC class is registered in 2 of our 19 countries.

ATC QI07AO01

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedLetifendATCQI07AO01REGISTER NO.FI-REL-REL46459PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Rec.protein q from leishmania infantum mon-1 is registered in 2 of 19 countries.

Countries holding a registration under ATC QI07AO01 (leishmania), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 1 of them publish a price we can compare per daily dose

Rec.protein q from leishmania infantum mon-1 · ATC QI07AO01

2 / 19 countries

  • Denmark
  • Finlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Rec.Protein Q from Leishmania infantum MON-1
Manufacturer
LETI Pharma, S.L.U.
Country
Finland (FI)
ATC code
QI07AO01
ATC class
Leishmania
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b04fc1e5-e6ae-49d1-b300-a2e3745b528f
GET /v1/drugs/b04fc1e5-e6ae-49d1-b300-a2e3745b528f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "kuiva-aine, kylmäkuivattu, ja liuotin, injektionestettä varten",
  "route": "Ihon alle",
  "ddd_unit": null,
  "strength": null,
  "atc_label": "Leishmania",
  "ma_number": null,
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": "EU/2/16/195/001-008",
  "fimea_rel_id": "REL46459",
  "authorised_at": "2016-04-22"
}

See everything about rec.protein q from leishmania infantum mon-1.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.